 | • レポートコード：MRC309Z7585 • 出版社/出版日：GlobalInfoResearch / 2023年9月20日 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| GlobalInfoResearchの最新の調査によると、世界の腫瘍早期スクリーニングキットの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。 このレポートは、世界の腫瘍早期スクリーニングキット市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。 市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。 本レポートの主な目的は次のとおりです。 - 世界および主要国の市場機会の規模を決定するため - 腫瘍早期スクリーニングキットの成長可能性を評価するため - 各製品および最終用途市場の将来の成長を予測するため - 市場に影響を与える競争要因を評価するため 腫瘍早期スクリーニングキット市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメント ・肺がん、直腸がん、乳がん、その他 用途別セグメント ・病院、診療所、その他 主要な市場プレーヤー ・Guardant、Exact Sciences、Illumina、Epiginomics AG、Freenome、Bio-techne、Nuohui Health、Ed Bio、Amison Life Sciences、Akron Medical、Sharp creature、Borcheng Technology、Transview Life Science and Technology 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、腫瘍早期スクリーニングキット製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な腫瘍早期スクリーニングキットメーカーの企業概要、2019年～2022年までの腫瘍早期スクリーニングキットの価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な腫瘍早期スクリーニングキットメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2018年～2029年までの地域別腫瘍早期スクリーニングキットの販売量、売上、成長性を示しています。 ・第5、6章では、2018年～2029年までの腫瘍早期スクリーニングキットの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での腫瘍早期スクリーニングキット市場予測を収録しています。 ・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。 ・第13章では、主要な原材料、主要なサプライヤー、および腫瘍早期スクリーニングキットの産業チェーンを掲載しています。 ・第14、15章では、腫瘍早期スクリーニングキットの販売チャネル、販売業者、顧客、調査結果について説明します。 ***** 目次(一部) ***** ・市場概要 - 腫瘍早期スクリーニングキットの概要 - 種類別分析（2018年vs2022年vs2029年）：肺がん、直腸がん、乳がん、その他 - 用途別分析（2018年vs2022年vs2029年）：病院、診療所、その他 - 世界の腫瘍早期スクリーニングキット市場規模・予測 - 世界の腫瘍早期スクリーニングキット生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Guardant、Exact Sciences、Illumina、Epiginomics AG、Freenome、Bio-techne、Nuohui Health、Ed Bio、Amison Life Sciences、Akron Medical、Sharp creature、Borcheng Technology、Transview Life Science and Technology ・メーカー別市場シェア・市場集中度 ・地域別市場分析2018年-2029年 ・種類別分析2018年-2029年：肺がん、直腸がん、乳がん、その他 ・用途別分析2018年-2029年：病院、診療所、その他 ・腫瘍早期スクリーニングキットの北米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・腫瘍早期スクリーニングキットのヨーロッパ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・腫瘍早期スクリーニングキットのアジア市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・腫瘍早期スクリーニングキットの南米市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・腫瘍早期スクリーニングキットの中東・アフリカ市場 - 種類別市場規模2018年-2029年 - 用途別市場規模2018年-2029年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析） ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
According to our (Global Info Research) latest study, the global Tumor Early Screening Kit market size was valued at USD 30350 million in 2022 and is forecast to a readjusted size of USD 61910 million by 2029 with a CAGR of 10.7% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
A tumor early screening kit refers to a diagnostic test or kit designed to detect the presence of tumors or cancerous cells at an early stage. These kits are typically used for screening individuals who may be at higher risk for developing certain types of cancer or for population-wide cancer screening programs.
This report is a detailed and comprehensive analysis for global Tumor Early Screening Kit market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Tumor Early Screening Kit market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Tumor Early Screening Kit market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Tumor Early Screening Kit market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Tumor Early Screening Kit market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023.
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Tumor Early Screening Kit
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace.
This report profiles key players in the global Tumor Early Screening Kit market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Guardant, Exact Sciences, Illumina, Epiginomics AG and Freenome, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Tumor Early Screening Kit market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Lung Cancer
Rectal Cancer
Breast Cancer
Other
Market segment by Application
Hospital
Clinic
Other
Major players covered
Guardant
Exact Sciences
Illumina
Epiginomics AG
Freenome
Bio-techne
Nuohui Health
Ed Bio
Amison Life Sciences
Akron Medical
Sharp creature
Borcheng Technology
Transview Life Science and Technology
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Tumor Early Screening Kit product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Tumor Early Screening Kit, with price, sales, revenue and global market share of Tumor Early Screening Kit from 2018 to 2023.
Chapter 3, the Tumor Early Screening Kit competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Tumor Early Screening Kit breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Tumor Early Screening Kit market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Tumor Early Screening Kit.
Chapter 14 and 15, to describe Tumor Early Screening Kit sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Tumor Early Screening Kit
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Tumor Early Screening Kit Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Lung Cancer
1.3.3 Rectal Cancer
1.3.4 Breast Cancer
1.3.5 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Tumor Early Screening Kit Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Tumor Early Screening Kit Market Size & Forecast
1.5.1 Global Tumor Early Screening Kit Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Tumor Early Screening Kit Sales Quantity (2018-2029)
1.5.3 Global Tumor Early Screening Kit Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Guardant
2.1.1 Guardant Details
2.1.2 Guardant Major Business
2.1.3 Guardant Tumor Early Screening Kit Product and Services
2.1.4 Guardant Tumor Early Screening Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Guardant Recent Developments/Updates
2.2 Exact Sciences
2.2.1 Exact Sciences Details
2.2.2 Exact Sciences Major Business
2.2.3 Exact Sciences Tumor Early Screening Kit Product and Services
2.2.4 Exact Sciences Tumor Early Screening Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Exact Sciences Recent Developments/Updates
2.3 Illumina
2.3.1 Illumina Details
2.3.2 Illumina Major Business
2.3.3 Illumina Tumor Early Screening Kit Product and Services
2.3.4 Illumina Tumor Early Screening Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Illumina Recent Developments/Updates
2.4 Epiginomics AG
2.4.1 Epiginomics AG Details
2.4.2 Epiginomics AG Major Business
2.4.3 Epiginomics AG Tumor Early Screening Kit Product and Services
2.4.4 Epiginomics AG Tumor Early Screening Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Epiginomics AG Recent Developments/Updates
2.5 Freenome
2.5.1 Freenome Details
2.5.2 Freenome Major Business
2.5.3 Freenome Tumor Early Screening Kit Product and Services
2.5.4 Freenome Tumor Early Screening Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Freenome Recent Developments/Updates
2.6 Bio-techne
2.6.1 Bio-techne Details
2.6.2 Bio-techne Major Business
2.6.3 Bio-techne Tumor Early Screening Kit Product and Services
2.6.4 Bio-techne Tumor Early Screening Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bio-techne Recent Developments/Updates
2.7 Nuohui Health
2.7.1 Nuohui Health Details
2.7.2 Nuohui Health Major Business
2.7.3 Nuohui Health Tumor Early Screening Kit Product and Services
2.7.4 Nuohui Health Tumor Early Screening Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Nuohui Health Recent Developments/Updates
2.8 Ed Bio
2.8.1 Ed Bio Details
2.8.2 Ed Bio Major Business
2.8.3 Ed Bio Tumor Early Screening Kit Product and Services
2.8.4 Ed Bio Tumor Early Screening Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Ed Bio Recent Developments/Updates
2.9 Amison Life Sciences
2.9.1 Amison Life Sciences Details
2.9.2 Amison Life Sciences Major Business
2.9.3 Amison Life Sciences Tumor Early Screening Kit Product and Services
2.9.4 Amison Life Sciences Tumor Early Screening Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Amison Life Sciences Recent Developments/Updates
2.10 Akron Medical
2.10.1 Akron Medical Details
2.10.2 Akron Medical Major Business
2.10.3 Akron Medical Tumor Early Screening Kit Product and Services
2.10.4 Akron Medical Tumor Early Screening Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Akron Medical Recent Developments/Updates
2.11 Sharp creature
2.11.1 Sharp creature Details
2.11.2 Sharp creature Major Business
2.11.3 Sharp creature Tumor Early Screening Kit Product and Services
2.11.4 Sharp creature Tumor Early Screening Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Sharp creature Recent Developments/Updates
2.12 Borcheng Technology
2.12.1 Borcheng Technology Details
2.12.2 Borcheng Technology Major Business
2.12.3 Borcheng Technology Tumor Early Screening Kit Product and Services
2.12.4 Borcheng Technology Tumor Early Screening Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Borcheng Technology Recent Developments/Updates
2.13 Transview Life Science and Technology
2.13.1 Transview Life Science and Technology Details
2.13.2 Transview Life Science and Technology Major Business
2.13.3 Transview Life Science and Technology Tumor Early Screening Kit Product and Services
2.13.4 Transview Life Science and Technology Tumor Early Screening Kit Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Transview Life Science and Technology Recent Developments/Updates
3 Competitive Environment: Tumor Early Screening Kit by Manufacturer
3.1 Global Tumor Early Screening Kit Sales Quantity by Manufacturer (2018-2023)
3.2 Global Tumor Early Screening Kit Revenue by Manufacturer (2018-2023)
3.3 Global Tumor Early Screening Kit Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Tumor Early Screening Kit by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Tumor Early Screening Kit Manufacturer Market Share in 2022
3.4.2 Top 6 Tumor Early Screening Kit Manufacturer Market Share in 2022
3.5 Tumor Early Screening Kit Market: Overall Company Footprint Analysis
3.5.1 Tumor Early Screening Kit Market: Region Footprint
3.5.2 Tumor Early Screening Kit Market: Company Product Type Footprint
3.5.3 Tumor Early Screening Kit Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Tumor Early Screening Kit Market Size by Region
4.1.1 Global Tumor Early Screening Kit Sales Quantity by Region (2018-2029)
4.1.2 Global Tumor Early Screening Kit Consumption Value by Region (2018-2029)
4.1.3 Global Tumor Early Screening Kit Average Price by Region (2018-2029)
4.2 North America Tumor Early Screening Kit Consumption Value (2018-2029)
4.3 Europe Tumor Early Screening Kit Consumption Value (2018-2029)
4.4 Asia-Pacific Tumor Early Screening Kit Consumption Value (2018-2029)
4.5 South America Tumor Early Screening Kit Consumption Value (2018-2029)
4.6 Middle East and Africa Tumor Early Screening Kit Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Tumor Early Screening Kit Sales Quantity by Type (2018-2029)
5.2 Global Tumor Early Screening Kit Consumption Value by Type (2018-2029)
5.3 Global Tumor Early Screening Kit Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Tumor Early Screening Kit Sales Quantity by Application (2018-2029)
6.2 Global Tumor Early Screening Kit Consumption Value by Application (2018-2029)
6.3 Global Tumor Early Screening Kit Average Price by Application (2018-2029)
7 North America
7.1 North America Tumor Early Screening Kit Sales Quantity by Type (2018-2029)
7.2 North America Tumor Early Screening Kit Sales Quantity by Application (2018-2029)
7.3 North America Tumor Early Screening Kit Market Size by Country
7.3.1 North America Tumor Early Screening Kit Sales Quantity by Country (2018-2029)
7.3.2 North America Tumor Early Screening Kit Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Tumor Early Screening Kit Sales Quantity by Type (2018-2029)
8.2 Europe Tumor Early Screening Kit Sales Quantity by Application (2018-2029)
8.3 Europe Tumor Early Screening Kit Market Size by Country
8.3.1 Europe Tumor Early Screening Kit Sales Quantity by Country (2018-2029)
8.3.2 Europe Tumor Early Screening Kit Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Tumor Early Screening Kit Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Tumor Early Screening Kit Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Tumor Early Screening Kit Market Size by Region
9.3.1 Asia-Pacific Tumor Early Screening Kit Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Tumor Early Screening Kit Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Tumor Early Screening Kit Sales Quantity by Type (2018-2029)
10.2 South America Tumor Early Screening Kit Sales Quantity by Application (2018-2029)
10.3 South America Tumor Early Screening Kit Market Size by Country
10.3.1 South America Tumor Early Screening Kit Sales Quantity by Country (2018-2029)
10.3.2 South America Tumor Early Screening Kit Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Tumor Early Screening Kit Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Tumor Early Screening Kit Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Tumor Early Screening Kit Market Size by Country
11.3.1 Middle East & Africa Tumor Early Screening Kit Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Tumor Early Screening Kit Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Tumor Early Screening Kit Market Drivers
12.2 Tumor Early Screening Kit Market Restraints
12.3 Tumor Early Screening Kit Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Tumor Early Screening Kit and Key Manufacturers
13.2 Manufacturing Costs Percentage of Tumor Early Screening Kit
13.3 Tumor Early Screening Kit Production Process
13.4 Tumor Early Screening Kit Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Tumor Early Screening Kit Typical Distributors
14.3 Tumor Early Screening Kit Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer